Mercer Global Advisors Inc Bridge Bio Pharma, Inc. Transaction History
Mercer Global Advisors Inc
- $35.2 Billion
- Q1 2024
A detailed history of Mercer Global Advisors Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 14,271 shares of BBIO stock, worth $356,775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,271
Previous 14,172
0.7%
Holding current value
$356,775
Previous $572,000
22.9%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BBIO
# of Institutions
285Shares Held
170MCall Options Held
7.41MPut Options Held
2.61M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$777 Million40.56% of portfolio
-
Viking Global Investors LP25.1MShares$628 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$262 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$152 Million64.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.71B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...